Amoun was founded as an importation and distribution company of pharmaceutical products in 1976.
Amoun’s ﬁrst factory ABI (Advanced Biochemical Industries) was bought by GlaxoWellcome Company in 1989.
Amoun’s second factory “APIC” (Amoun Pharmaceutical Industries Co.) was also sold to GlaxoWellcome in 1998 and is now GlaxoWellcome Egypt.
Amoun now has established its third state-of-the-art manufacturing plant in Egypt.
Amoun products cover most of the therapeutic classes: antirheumatics, antihistaminics, gastrointestinals, cardiovasculars, antipyretics, analgesics, physical well-being (vitamins and food supplements), etc.
Amoun is the ﬁrst Egyptian pharmaceutical company to open sister companies in the USA, Romania, Russia and Kenya. Amoun exports to 19 other European, Arab and African countries.
According to IMS Data:
Amoun enjoyed the highest growth rate during the last 5 years, among all pharmaceutical companies operat-ing in Egypt. Amoun was the ﬁrst pharmaceutical company in Egypt to obtain the ISO 9001 in April 1996, and ISO 14001 in May 1997. Amoun was the ﬁrst pharmaceutical company in Egypt to be honoured with the Unido prize for innovation in Africa in 1997 by the United Nations.